儿科SCA2的两个面孔
Nicolas Rive Le Gouard1, Maissa G Bah1,2, Giulia Coarelli3
1Département de Génétique médicale, Hôpital Armand Trousseau et Groupe Hospitalier Pitié-Salpêtrière, APHP Sorbonne Université, Paris, France.
European journal of neurology
|July 31, 2025
概括
儿科脊髓小脑动症2型 (SCA2) 在儿童中呈现两种不同的表型,婴儿和青少年,基于ATXN2基因中的CAG重复大小. 诊断可以通过有针对性的基因测试来实现,母亲传播是显著的.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 2型脊髓小脑动症 (SCA2) 通常是一种成人发病的自体主导神经退行性疾病.
- 在ATXN2基因中扩展的CAG重复与SCA2.2的儿科发病有关.
- 儿科SCA2的自然史尚未全面描述.
研究的目的:
- 在儿科患者中描述2型脊髓小脑动症 (SCA2) 的自然史和临床特征.
- 在儿科SCA2.2中识别不同的表型组.
- 建立基因参数来区分这些群体.
主要方法:
- 分析了来自17个机构22名儿科SCA2患者的临床和遗传数据.
- 与之前报告的20例儿科SCA2病例进行比较.
- 基因分析的重点是ATXN2基因中的CAG重复大小.
主要成果:
- 儿科SCA2表现出双模态的表型:一个婴儿组 (n=9) 发育迟缓,和缩,一个青少年组 (n=13) 类似于成人开始的SCA2.
- 在ATXN2中,88±4的CAG重复值区分了婴儿和青少年组.
- 在22%的病例中,SCA2是从母亲遗传的,包括三个婴儿表现,并且独立于父母的起源.
结论:
- 儿科SCA2具有可识别的双模态表型谱,与SCA7的连续谱不同.
- 对ATXN2 CAG重复数的有针对性的分析有助于诊断儿科SCA2.2.
- 遗传咨询应解决儿科SCA2中母亲传播的显著率.
相关概念视频
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
01:19Clinical Applications of Epidermal Stem Cells
2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K